Literature DB >> 746597

Estrogen receptor in human breast cancer in relation to tumor morphology and endocrine therapy.

Z Paszko, H Padzik, M Dabska, F Pienkowska.   

Abstract

The presence of estrogen receptors (ER) was determined in 111 human breast cancer specimens. In 61% of the tumors, specific estrogen binding was found and in 39% of the tumors ER was absent. In 69 tumors no correlation was found between the histological grading of the tumor and the level of ER. The values of ER in tumors from patients over 50 years of age were usually much higher than those for patients under 50 years of age. Different methods of endocrine therapy were applied in 20 patients. In 10 of 15 patients with ER positive tumors, endocrine therapy resulted in remission. Only 1 of 5 patients with ER negative tumors responded with remission. It is concluded that estimation of ER in tumor tissue is helpful in the selection of patients for endocrine therapy.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 746597     DOI: 10.1177/030089167806400507

Source DB:  PubMed          Journal:  Tumori        ISSN: 0300-8916


  3 in total

1.  Correlation of steroid hormone receptor levels with histological grading in human breast cancer.

Authors:  H Würz; P Citoler; K D Schulz; B Roos; R Kaiser
Journal:  Klin Wochenschr       Date:  1980-06-16

2.  Simultaneous occurrence of receptors for estradiol, progesterone, and dihydrotestosterone in canine mammary tumors.

Authors:  H Elling; F R Ungemach
Journal:  J Cancer Res Clin Oncol       Date:  1983       Impact factor: 4.553

Review 3.  Fulvestrant: an oestrogen receptor antagonist with a novel mechanism of action.

Authors:  C K Osborne; A Wakeling; R I Nicholson
Journal:  Br J Cancer       Date:  2004-03       Impact factor: 7.640

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.